Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 42, Issue 2, 1997, Pages 200-207

  Williams, T L ^a,c   Day, N C ^a   Ince, P G ^a   Kamboj, R K ^b   Shaw, P J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NPS Pharmaceutical Inc   (United States)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SPINAL CORD MOTONEURON; STOICHIOMETRY;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CALCIUM; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; NEURONS; RECEPTORS, AMPA; REFERENCE VALUES; SPINAL CORD;

EID: 0030789347     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420211     Document Type: Article

References (41)

1. Choi DW. Glutamate neurotoxicity and disease of the nervous system. Neuron 1988;1:623-634
2. Mayer ML, Miller RJ. Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons. Trends Pharmacol Sci 1990;11:254-260
3. Zeman S, Lloyd C, Meldrum B, Leigh PN. Excitatory amino acids, free radicals and the pathogenesis of motor neurone disease. Neuropathol Appl Neurobiol 1994;20:219-231
4. Shaw PJ. Excitotoxicity and motor neurone disease: a review of the evidence. J Neurol Sci 1994;124(suppl):6-13
5. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 1995;68:7-20
6. Williams TL, Ince PG, Oakley AE, Shaw PJ. An immunocytochemical study of the distribution of AMPA selective glutamate receptor subunits in the normal human motor system. Neuroscience 1996;74:185-198
7. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991;252:851-853
8. Burnashev N, Monyer H, Seeburg PH, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992;8:189-198
9. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108
10. 1E voltage-dependent calcium channel subunits in the human hippocampus and parahippocampal gyrus. Neuroscience 1996;71:1013-1024
11. Day NC, Williams TL, Ince PG, et al. Distribution of AMPA-selective glutamate receptor subunits in the human hippocampus and cerebellum. Brain Res Mol Brain Res 1995;31:17-32
12. Shaw PJ, Forrest V, Ince PG, et al. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995;4:209-216
13. Tsai G, Staugh-Slusher B, Sim L, et al. Reductions in acidic amino acids and N-acetyl-aspartyl glutamate (NAAG) in amyotrophic lateral sclerosis. Brain Res 1991;556:151-156
14. 3H]D-Aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res 1994;655:195-201
15. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;336:1464-1468
16. Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
17. Couratier P, Hugon J, Sindou P, et al. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to AMPA/kainate receptors. Lancet 1993;341:265-268
18. 3H]MK-801. Brain Res 1994;637:297-302
19. 3H]kainate. Brain Res 1994;655:186-194
20. Kew JJM, Leigh PN, Playford ED, et al. Cortical function in amyotrophic lateral sclerosis. Brain 1993;116:655-680
21. Eisen A, Pant B, Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 1993;20:11-16
22. Mills KR. Motor neurone disease: studies of the corticospinal excitation of single motoneurons by magnetic brain stimulation. Brain 1995;118:971-982
23. Hugon J, Vallet JM. Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid. Neurosci Lett 1990;119:45-48
24. Rothstein JD, Lin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-6595
25. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and glutamate clearance. Neuron 1996; 16:675-686
26. Lacomblez L, Bensimon G, Leigh PN, et al for the Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347:1425-1431
27. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-157
28. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses. Ann Neurol 1992;31:119-130
29. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451: 205-212
30. Choi DW. Calcium: still centre-stage in hypoxic-ischaemic neuronal death. Trends Neurosci 1995;18:58-60
31. 2+ dependent. Neuroreport 1995;6:945-948
32. Margulies JE, Cohen RW, Levine MS, Watson JB. Decreased GluR2(B) receptor subunit mRNA expression in cerebellar neurons at risk for degeneration. Dev Neurosci 1993;15:110-120
33. 3H]CNQX in human motor cortex, brainstem and spinal cord. Brain Res 1993;630:75-81
34. Jansen KLR, Faull RM, Dragunow M, Waldvogel H. Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett 1990;108:53-57
35. Tölle TR, Berthele A, Zieglgänsberger W, et al. Flip and flop variants of AMPA receptors in the rat lumbar spinal cord. Eur J Neurosci 1995;7:1414-1419
36. Jakowec MW, Yen L, Kalb RG. In situ hybridization analysis of AMPA receptor gene expression in the developing rat spinal cord. Neuroscience 1995;67:909-920
37. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 1996;16:4069-4079
38. Regan RF. The vulnerability of spinal cord motor neurons to excitotoxic injury: comparison with cortical neurons. Neurosci Lett 1996;213:9-12
39. Petralia RS, Wang Y-X, Mayat E, Wenthold RJ. A GluR2 selective antibody shows that GluR2 AMPA receptor protein expression varies among hippocampal and cerebral cortical neurons. Soc Neurosci Abstr 1996;22:1995 (Abstract)
40. Ince PG, Stout N, Shaw PJ, et al. Parvalbumin and calbindin D-28K in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993;19:291-299
41. Alexianu ME, Ho B-K, Mohamed AH, et al. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994;36:846-858